“The Therapeutic Applications Of Aptamers And Aptamer-Conjugated Nanoparticles In Cancer, Inflammatory And Viral Diseases”, Journal of Pharmaceutical Negative Results, pp. 1936–1942, Nov. 2022, doi: 10.47750/pnr.2022.13.S03.289.